CN1237176A - 用作fpt抑制剂的三环化合物 - Google Patents

用作fpt抑制剂的三环化合物 Download PDF

Info

Publication number
CN1237176A
CN1237176A CN97199601A CN97199601A CN1237176A CN 1237176 A CN1237176 A CN 1237176A CN 97199601 A CN97199601 A CN 97199601A CN 97199601 A CN97199601 A CN 97199601A CN 1237176 A CN1237176 A CN 1237176A
Authority
CN
China
Prior art keywords
ras
cells
added
dichloromethane
tumour cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97199601A
Other languages
English (en)
Chinese (zh)
Inventor
F·G·恩乔罗格
J·M·克莱
刘怡宗
A·G·塔弗拉斯
A·阿芳索
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CN1237176A publication Critical patent/CN1237176A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN97199601A 1996-09-13 1997-09-11 用作fpt抑制剂的三环化合物 Pending CN1237176A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71390896A 1996-09-13 1996-09-13
US08/713,908 1996-09-13

Publications (1)

Publication Number Publication Date
CN1237176A true CN1237176A (zh) 1999-12-01

Family

ID=24868035

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97199601A Pending CN1237176A (zh) 1996-09-13 1997-09-11 用作fpt抑制剂的三环化合物

Country Status (6)

Country Link
EP (1) EP0927181A1 (fr)
JP (1) JP2001500505A (fr)
CN (1) CN1237176A (fr)
AU (1) AU4337497A (fr)
CA (1) CA2265764A1 (fr)
WO (1) WO1998011106A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111548297A (zh) * 2020-06-16 2020-08-18 大桐制药（中国）有限责任公司 一种维达列汀的合成方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228865B1 (en) * 1997-06-17 2001-05-08 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
CA2318088A1 (fr) 1998-01-21 1999-07-29 Yoshisuke Nakasato Antagonistes du recepteur de la chemokine et procedes d'emploi desdits antagonistes
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AU2331999A (en) 1998-01-21 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US7342016B2 (en) * 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
WO2005017160A2 (fr) 2003-08-13 2005-02-24 Children's Hospital Medical Center Mobilisation de cellules hematopoietques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5700806A (en) * 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
IL125062A (en) * 1995-12-22 2003-11-23 Schering Corp Tricyclic amides and pharmaceutical compositions containing them for inhibition of g-protein function and for treatment of proliferative diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111548297A (zh) * 2020-06-16 2020-08-18 大桐制药（中国）有限责任公司 一种维达列汀的合成方法

Also Published As

Publication number Publication date
WO1998011106A1 (fr) 1998-03-19
CA2265764A1 (fr) 1998-03-19
JP2001500505A (ja) 2001-01-16
EP0927181A1 (fr) 1999-07-07
AU4337497A (en) 1998-04-02

Similar Documents

Publication Publication Date Title
CN1267291A (zh) 新的n－取代的脲的法呢基蛋白转移酶抑制剂
CN1104427C (zh) 法呢基蛋白转移酶的三环抑制剂
CN1094937C (zh) 具抑制法呢基转化酶作用的喹唑啉酮类
CN1267289A (zh) 用于抑制g－蛋白功能和治疗增生性疾病的羧基哌啶基乙酰胺三环化合物(法呢基蛋白转移酶抑制剂)
CN1238770A (zh) 为法呢基蛋白转移酶抑制剂的三环抗肿瘤化合物
CN1237176A (zh) 用作fpt抑制剂的三环化合物
CN1226248A (zh) 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺
CN1680379A (zh) 2－吡啶基－6,7,8,9－四氢嘧啶并[1,2－а]嘧啶－4－酮和7－吡啶基－2,3－二氢咪唑并[1,2－а]嘧啶－5（1H）酮衍生物
CN1119345C (zh) 用作法呢基蛋白转移酶抑制剂的苯并(5.6)环庚并吡啶化合物
CN1122031C (zh) 用作法呢基蛋白转移酶抑制剂的取代的苯并芳庚并吡啶衍生物
CN1266433A (zh) 用于抑制法呢基蛋白转移酶的苯并吡啶并环庚烷化合物
CN1267288A (zh) 用作法呢基蛋白转移酶抑制剂的三环酮酰胺衍生物
CN1113064C (zh) 顺式取代氨基环丙烷衍生物
CN1267297A (zh) 用作法呢基蛋白转移酶抑制剂的苯并(5.6)环庚并吡啶环脲和内酰胺
CN1267290A (zh) 新的法呢基－蛋白转移酶的三环磺酰胺抑制剂
CN1183778A (zh) 喹啉羧酸衍生物
US6071907A (en) Tricyclic compounds useful as FPT inhibitors
CN1346355A (zh) 新的法尼基蛋白转移酶抑制剂
CN1117745C (zh) 用作法呢基蛋白转移酶抑制剂的新的三环n－氰亚胺类化合物
CN1443763A (zh) 制备喹喔啉二酮的中间体
CN1411457A (zh) 取代的吡咯类化合物
CN1155595C (zh) 作为用于治疗癌症的抗增殖剂的取代的吡咯类化合物
CN1198816C (zh) 新的法尼基蛋白转移酶抑制剂
CN1134433C (zh) 法呢基蛋白转移酶的新的氨基氧酰胺三环抑制剂
CN1109685C (zh) 用作法呢基蛋白转移酶抑制剂的取代的苯并芳庚并吡啶衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication